From the results of this study, we found that ITP-treated mice had stronger SOD (contained Cu/Zn-SOD and Mn-SOD) activities in serum and tissue than KTP-treated mice. The gene discussed is SOD2; the disease is autoimmune thrombocytopenic purpura.